ArticleMicrobial cell factories2026
Scalable secretory production of influenza A (H1N1) hemagglutinin HA1 in Pichia pastoris through expression and process optimization.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEfficient and scalable production of viral antigens remains a key challenge in the development of recombinant subunit vaccines and diagnostic reagents. Microbial expression systems, particularly Pichia pastoris (P. pastoris), offer a promising platform for producing complex viral glycoproteins with appropriate folding and post-translational modifications.
resultsIn this study, the hemagglutinin head domain (HA1) of influenza A (H1N1) virus was expressed as a secreted recombinant protein in P. pastoris GS115. The HA1 gene was codon-optimized and expressed under the control of the methanol-inducible AOX1 promoter with an α-factor signal peptide. Multicopy integrants were enriched using G418 selection, and expression conditions were systematically optimized. Under shake-flask induction, the selected recombinant strain produced up to 0.375 g/L of rHA1 in the culture supernatant. The protein was efficiently purified by Ni-NTA affinity chromatography to a purity exceeding 95%. PNGase F digestion confirmed N-linked glycosylation. Limited functional validation demonstrated that the yeast-expressed rHA1 retained antigenic integrity, as evidenced by the induction of rHA1-specific antibodies and hemagglutination-inhibiting activity in a murine model.
conclusionsThese results establish P. pastoris as an effective microbial cell factory for the high-level secretion of influenza HA1 protein. The optimized expression and purification strategy provides a scalable and cost-efficient framework for microbial production of viral antigens and may be applicable to other glycoproteins of biomedical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.